What are the opening hours?

Monday 9am - 6pm Tuesday 9am - 6pm Wednesday 9am - 6pm Thursday 9am - 6pm Friday 9am - 6pm

Excelra

Home
India
Uppal
Excelra

Excelra's data and analytics solutions empower innovation in life sciences across the value chain from discovery to market.

The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years, Excelra has been the preferred data and analytics partner to over 90 global clients including 15 of the top 20 large Pharma companies.

29/01/2026

From first hit to market - is your small-molecule data truly decision-ready?
Explore the full journey: https://na2.hubs.ly/H03k__D0

Small-molecule drug discovery is one of the most data-intensive pipelines in life sciences. Yet fragmented SAR, ADMET, and assay data often slow optimization, increase risk, and delay critical go/no-go decisions.

Our latest whitepaper breaks down the end-to-end small-molecule lifecycle and shows how curated intelligence from GOSTAR™ helps teams move faster from data to insight, improving candidate quality and accelerating development timelines.

Download the whitepaper and power smarter small-molecule discovery.

23/01/2026

Is your diagnostics interpretation workflow ready to scale with growing data volumes? https://na2.hubs.ly/H03cyz00

As sample complexity and data fragmentation increase, diagnostics teams face growing pressure across integration, standardization, AI-readiness, and compliance workflows. Excelra helps build scalable, interpretation-ready data foundations that enable faster insights, consistent reporting, and clinical-grade outcomes.

Discover how Excelra is helping diagnostics teams scale smarter.

22/01/2026

Meet our experts at The Festival of Genomics & Biodata 2026!

Join us in London, UK, on January 28–29, 2026, and discover how Excelra’s advanced genomics, biodata, and bioinformatics solutions are helping life sciences organizations accelerate research and enable data-driven innovation.

Connect with our experts to explore scalable data integration, FAIR data strategies, and analytics-driven insights that streamline scientific workflows and power next-generation discovery.

19/01/2026

Scaling diagnostic data isn’t just about volume — it’s about enabling faster, more reliable insights.

From siloed datasets and performance bottlenecks to compliance complexity, infrastructure limitations are becoming a critical barrier for diagnostics teams.
Scalable, cloud-ready data architectures with standardized metadata and integrated analytics are key to transforming growing diagnostic data into actionable intelligence.

👉 Explore how Excelra helps build scalable, discovery-ready data ecosystems: https://na2.hubs.ly/H035-Pr0

14/01/2026

We’re excited to share the latest update on GOSTARᵀᴹ Small Molecules, reinforcing its position as a trusted foundation for data-driven drug discovery and optimization: https://na2.hubs.ly/H0316wb0

This update introduces 1M+ newly curated SAR data points, along with expanded coverage across compounds, ADMET, targets, patents, and literature - enabling medicinal chemists, data scientists, and portfolio teams to make more confident, evidence-based decisions.

Discover how richer SAR density and broader chemical space can accelerate smarter design, optimization, and competitive insights.

12/01/2026

Missed our live webinar? You can now watch the session on demand: https://na2.hubs.ly/H02-Jyf0

Discover how integrating Clinical Pharmacology with Pharmacometrics Modelling enables Model-Informed Drug Development (MIDD) and supports data-driven clinical and regulatory decisions.

In this expert-led session, Dr. Srinivas Martha, Program Manager – Clinical Pharmacology Services, shares practical insights on translating complex clinical data into actionable development strategies.

09/01/2026

Accelerating drug discovery starts with breaking down data silos.
Explore how an Integrated Genomic, Target & Clinical Data Lake unifies 20+ internal and external data sources into a FAIR-compliant, cloud-scale platform: https://na2.hubs.ly/H02ZKpY0

AI-driven analytics, scalable cloud architecture, and standardized metadata enable faster biomarker discovery, target validation, and precision medicine outcomes. See how Excelra helps global pharma teams transform fragmented genomic and clinical data into discovery-ready intelligence.

05/01/2026

Celebrating meaningful partnerships built on trust, science, and shared purpose.
We’re grateful for our long-standing collaboration with Fauna Bio, working together to curate high-quality functional datasets that support AI-driven discovery and therapeutic innovation.

As Ashley Zehnder, CEO of Fauna Bio, shares: “We couldn’t do the work that we do without Excelra.”

Thank you for the confidence, collaboration, and continued partnership.
Here’s to advancing science together and achieving many more milestones ahead.

30/12/2025

Turning biomedical data into personalized therapies isn’t just about collecting more data — it’s about integrating, curating, and translating it into actionable insight: https://na2.hubs.ly/H02QQGw0

As precision medicine advances, fragmented omics, biomarker, clinical, and real-world datasets often slow progress. Our latest blog explores how AI-driven analytics and harmonized data ecosystems help overcome these barriers and enable the right therapy for the right patient at the right time.

Read the blog to see how Excelra is accelerating precision medicine through AI, multi-omics integration, and real-world evidence.

24/12/2025

50% faster RNA-seq alignment, turning a legacy GSNAP pipeline into a fault-tolerant, cloud-ready workflow. Read the full case study here: https://na2.hubs.ly/H02LHhl0

By refactoring a sequential GSNAP pipeline into a Nextflow-based, intelligently parallelized workflow with adaptive failure handling, the solution cut alignment wall-time by 50% while preserving high-sensitivity splice-aware mapping and reducing cloud compute costs.

This case study shows how fault-tolerant bioinformatics workflows and cloud-native automation accelerate large-scale RNA-seq analysis and biomarker discovery.

22/12/2025

Turning bioinformatics pipelines into insight isn’t just about running analyses — it’s about how those analyses are shared and understood:https://na2.hubs.ly/H02LHdC0

Most teams still rely on siloed, one-off post-pipeline scripts, leading to inconsistent results and limited reproducibility. Our latest blog explores how InnerSource brings shared, standardized analysis frameworks that make results clearer, reproducible, and easier to trust.

Read the blog to see how InnerSource transforms post-pipeline analysis into shared understanding and stronger scientific collaboration.

Address

7th Floor Wing B
Uppal
500039

Opening Hours

Monday	9am - 6pm
Tuesday	9am - 6pm
Wednesday	9am - 6pm
Thursday	9am - 6pm
Friday	9am - 6pm

Telephone

+91 40 6707 3333

Website

https://www.excelra.com/

Alerts

Be the first to know and let us send you an email when Excelra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Excelra:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Uppal?